South Korea's Pharma-Bio Firms to Invest $95 Million in COVID-19 Projects, an Industrial Info Market Brief
Attachment: SK COVID phamra 0920
Industrial Info is tracking 10 active projects related to COVID-19 equipement and treatments across South Korea, with a total investment of nearly $95 million. Seven projects, worth more than $62 million, are related to KF94 mask production.